Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Patient Educ Couns. 2011 Feb 5;85(3):390–397. doi: 10.1016/j.pec.2011.01.009

Table 2.

Outcomes By Treatment Group (mean (std) followed by confidence interval)

Characteristics No Visit Standard Enhanced P-value
Health status
WURSS-21 (Severity) 262.19 (214.18)
n=230,
(232.24, 292.15)		 262.97 (206.03)
n=246,
(235.11 290.83)		 257.07 (224.33)
n=237,
(226.16 287.98)		 0.95
WURSS-21 (Duration
in Days)		 6.75 (3.50)
n= 230,
(6.26, 7.24)		 6.96 (3.36)
n=246,
(6.51, 7.42)		 6.51 (3.58)
n=237,
(6.02, 7.01)		 0.36
Psychosocial
Empathy (CARE)
Scores		 N/A 35.36 (9.58)
n=244
(34.17, 36.56)		 45.65 (5.19)
n=237
(44.99, 46.30)		 <0.001
Liking clinician N/A 3.60 (0.91)
n=243
(3.48, 3.72)		 4.51 (0.65)
n=236
(4.42, 4.60)		 <0.001
Connectedness to
Clinician		 N/A 2.88 (1.10)
n=243,
(2.74, 3.01)		 3.95 (0.90)
n=236,
(3.84, 4.07)		 <0.001
Objective Markers
IL-8 change 134.1 (3940),
n=221,
(−428.13, 696.24)		 230 (6562)
n=234,
(−679.9, 1140)		 628 (4767),
n=216,
(−60,1316)		 0.58
Neutrophil Count
Change		 −3.48 (181.40)
n=213,
(−29.85, 22.88)		 11.95 (217.13)
n=224,
(−18.82, 42.72)		 28.89 (169.77)
n=211,
(4.10, 57.68)		 0.22
Length of Visit N/A 3:43 mins (1:06)
n=233		 8:34 mins (2:12)
n=224		 <0.001
*

p-values are based on one-way ANOVA for available data.